BRAINSTORM CELL THERAPEUTICS INC. Uncategorized Contracts & Agreements
23 Contracts & Agreements
- Description of the Companys Securities (Filed With SEC on March 30, 2023)
- Amendment No. 3 to Offer Letter Agreement, dated January 3, 2023, between Brainstorm Cell Therapeutics Inc. and Dr. Stacy Lindborg (Filed With SEC on January 4, 2023)
- Amendment No. 2 to Offer Letter Agreement dated September 18, 2022 between Brainstorm Cell Therapeutics Inc. and Dr. Stacy Lindborg (Filed With SEC on September 22, 2022)
- Offer letter, dated May 26, 2020, by and between Brainstorm Cell Therapeutics Inc. and Stacey Lindborg (Filed With SEC on February 4, 2021)
- Offer Letter by and between Brainstorm Cell Therapeutics Inc. and Anthony Waclawski (Filed With SEC on September 3, 2020)
- Offer letter, dated September 5, 2019, by and between Brainstorm Cell Therapeutics Inc. and Preetam Shah (Filed With SEC on November 14, 2019)
- Leak-Out Agreement (Filed With SEC on June 7, 2018)
- Notice of Award - CLIN2: Partnering Opportunity for Clinical Trial Stage Projects California Institute for Regenerative Medicine, August 25, 2017 (Filed With SEC on March 8, 2018)
- AMENDMENT NO. 3 TO SECOND AMENDED AND RESTATED RESEARCH ANDLICENSE AGREEMENT (Filed With SEC on March 9, 2016)
- SUBJECTTO MAXIM COMMITMENT COMMITTEE APPROVAL (Filed With SEC on January 8, 2015)
- AMENDMENT OF WARRANTS May 19, 2014 (Filed With SEC on August 12, 2014)
- Brainstorm Cell Therapeutics Inc. Second Amended and Restated DirectorCompensation Plan (adopted July 9, 2014) (Filed With SEC on July 10, 2014)
- Brainstorm Cell Therapeutics Inc. Second Amended and Restated DirectorCompensation Plan (adopted July 9, 2014) (Filed With SEC on July 10, 2014)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on June 13, 2014)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on June 29, 2012)
- WarrantAmendment Agreement May10, 2012 (Filed With SEC on May 11, 2012)
- FIRST AMENDMENTTO AGREEMENT (Filed With SEC on February 3, 2012)
- Amended and Restated Executive Director Agreement (Filed With SEC on November 16, 2011)
- BRAINSTORM CELL THERAPEUTICS INC. OPTION AGREEMENT Made effective as of the __ day of___ 2011 (Filed With SEC on August 15, 2011)
- Amendment to the Clinical Trial Agreement (Filed With SEC on August 15, 2011)
- CLINICAL TRIAL AGREEMENT (Filed With SEC on August 15, 2011)
- BRAINSTORMCELL THERAPEUTICS INC. SUBSCRIPTIONAGREEMENT (Filed With SEC on February 1, 2010)
- Amendment (Filed With SEC on August 24, 2009)
